Literature DB >> 10709311

Funding research into complementary medicine: the situation in Britain.

E Ernst1.   

Abstract

This article outlines the theoretical options for research funding for complementary medicine in Britain. Sponsorship from the National Health Service, the Medical Research Council, Medical Research Charities, the industry and private donations constitute the main potential sources. Surveys of the actual funding spent by these sources are evaluated. The data thus generated suggest that funds for research into complementary medicine are not readily available in the UK. Several suggestions are made to ameliorate this situation and the case for 'ring-fenced' funding is put forward, not least on the basis of international experience.

Mesh:

Year:  1999        PMID: 10709311     DOI: 10.1016/s0965-2299(99)80011-9

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  6 in total

Review 1.  The role of complementary and alternative medicine.

Authors:  E Ernst
Journal:  BMJ       Date:  2000-11-04

Review 2.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

Review 3.  Ethical problems arising in evidence based complementary and alternative medicine.

Authors:  E Ernst; M H Cohen; J Stone
Journal:  J Med Ethics       Date:  2004-04       Impact factor: 2.903

4.  Equivalence and Non-inferiority Trials of CAM.

Authors:  Edzard Ernst
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

Review 5.  Barriers to the conduct and application of research in complementary and alternative medicine: a systematic review.

Authors:  Yasamin Veziari; Matthew J Leach; Saravana Kumar
Journal:  BMC Complement Altern Med       Date:  2017-03-23       Impact factor: 3.659

6.  Herbal medicine research in Taiwan.

Authors:  Krishna Kaphle; Leang-Shin Wu; Nai-Yen Jack Yang; Jen-Hsou Lin
Journal:  Evid Based Complement Alternat Med       Date:  2006-02-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.